Bluebird Bio competitors and similar companiesClear all

Bluebird Bio's competitors and similar companies include Tanvex Biopharma, H3 Biomedicine, G1 Therapeutics, Ionis Pharmaceuticals, Genprex and Bellicum Pharmaceuticals.
Bluebird Bio
Bluebird Bio
Bluebird Bio is a developer of gene therapies for severe genetic diseases and cancer.
Tanvex Biopharma
Tanvex Biopharma
Tanvex Biopharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
H3 Biomedicine
H3 Biomedicine
H3 Biomedicine is a biopharmaceutical company that specializes in cancer genomics.
G1 Therapeutics
G1 Therapeutics
G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Genprex
Genprex
Genprex is a gene therapy company developing treatments for cancer and diabetes.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.
Founding Date
Founding Date
1992
Founding Date
2013
Founding Date
2011
Founding Date
2008
Founding Date
1989
Founding Date
2009
Founding Date
2004
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Paris, FR
München, DE
Athens, GR
Milano, IT
Utrecht, NL
Zug, CH
see more
Locations
New Taipei City, TW HQ
Irvine, US
San Diego, US
San Diego, US
Locations
Cambridge, US HQ
Locations
Durham, US HQ
Locations
Carlsbad, US HQ
Locations
West Lake Hills, US HQ
Austin, US
Locations
Houston, US HQ
Houston, US
Houston, US
South San Francisco, US
Employees
Employees
1,2134% increase
Employees
1487% decrease
Employees
4116% decrease
Employees
12217% increase
Employees
7577% decrease
Employees
814% increase
Employees
10738% decrease
Valuation ($)
Valuation ($)
436.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
287.4 m
Valuation ($)
5.6 b
Valuation ($)
64.5 m
Valuation ($)
10.9 m
Twitter followers
Twitter followers
10.5 k
Twitter followers
N/A
Twitter followers
476
Twitter followers
1.3 k
Twitter followers
4.3 k
Twitter followers
2.1 k
Twitter followers
583
Number of tweets (last 30 days)
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
1
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.8
Average likes per tweet (last 30 days)
6.4
Average likes per tweet (last 30 days)
8.8
Average likes per tweet (last 30 days)
2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
63.64%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
438682
Alexa Website Rank
309617
Alexa Website Rank
324558
Alexa Website Rank
411905
Alexa Website Rank
333062
Alexa Website Rank
386998
Alexa Website Rank
421105
Employee Rating
Employee Rating
3.6
Employee Rating
3.2
Employee Rating
3.6
Employee Rating
3.4
Employee Rating
3.6
Employee Rating
N/A
Employee Rating
2.7

Financial

Revenue (est.)
Revenue (est.)
$3.7m (FY, 2021)
Revenue (est.)
NT$5.4m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
$31.5m (FY, 2021)
Revenue (est.)
$810.5m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
NT$1.9m (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$10.8m (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Net income
Net income
($819.4m) (FY, 2021)
Net income
(NT$1.5b) (FY, 2021)
Net income
N/A
Net income
($148.4m) (FY, 2021)
Net income
($28.6m) (FY, 2021)
Net income
($19.6m) (FY, 2021)
Net income
($9.7m) (FY, 2021)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
40 (FY, 2020)
Patents (US)
161 (Jun, 2021)
Patents (US)
N/A
Patents (US)
N/A
Patents and Patent Applications
Patents and Patent Applications
1.2 k (FY, 2020)
Patents and Patent Applications
N/A
Patents and Patent Applications
N/A
Patents and Patent Applications
350 (FY, 2020)
Patents and Patent Applications
N/A
Patents and Patent Applications
N/A
Patents and Patent Applications
N/A

Funding

Total funding raised
Total funding raised
$ 409m
Total funding raised
$ 346.9m
Total funding raised
$ 200m
Total funding raised
$ 289.6m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Tanvex Biopharma
HQ
New Taipei City, TW
Employees
148↓ 7% decrease

Tanvex Biopharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.

View company
H3 Biomedicine
HQ
Cambridge, US

H3 Biomedicine is a biopharmaceutical company that specializes in cancer genomics.

View company
G1 Therapeutics
HQ
Durham, US
Employees
122↑ 17% increase

G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.

View company
Ionis Pharmaceuticals
HQ
Carlsbad, US
Employees
757↓ 7% decrease

Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.

View company